RMD - Insulet spikes as CEO buys over $1M shares
2023-08-30 10:11:37 ET
More on Insulet
- Insulet: Losing More Weight
- Insulet: High Growth Not Translating To Economic Value For Shareholders (Rating Downgrade)
- Insulet Corporation ( PODD ) Q2 2023 Earnings Call Transcript
- Insulet Corporation: Margins Are On A Diet
- Insulet downgraded at Baird; upgraded at Citi amid GLP1-linked selloff
- Insulet Non-GAAP EPS of $0.38 beats by $0.12, revenue of $396.5M beats by $11.4M
- Insulet, Tandem fall as Medtronic to buy insulin pump maker
- Seeking Alpha’s Quant Rating on Insulet
For further details see:
Insulet spikes as CEO buys over $1M shares